Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Clinical trial NCT05803382 · RECRUITING

Trial details

NCT number: NCT05803382
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Colorectal Carcinoma Metastatic Malignant Solid Neoplasm Stage IV Colorectal Cancer AJCC v8 Unresectable Colorectal Carcinoma Unresectable Malignant Solid Neoplasm

Start date: 2023-11-08
Primary completion: 2027-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.